The genetic silencing of IDO1 has consistently been reported to reduce the abundance of Treg cells and potentiate cytotoxic T cells [197], and enhance the anti-tumor immunity in metastatic hepatocellular carcinoma [198]. The gene discussed is IDO1; the disease is neoplasm.